$CCEL

CRYO CELL INTERNATIONAL INC

CIK:0000862692|SEC Filings

Consolidated Statements of Income - USD ($)	3 Months Ended		6 Months Ended
Consolidated Statements of Income - USD ($)	May 31, 2026	May 31, 2025	May 31, 2026	May 31, 2025
Revenue	$ 7,776,113	$ 7,928,843	$ 15,459,230	$ 15,897,723
Costs and Expenses:
Cost of sales	1,676,663	1,856,539	3,333,151	3,841,127
Selling, general and administrative expenses	4,617,999	4,257,857	9,629,846	8,896,142
Research, development and related engineering	99,781	131,711	165,542	229,854
Depreciation and amortization	184,329	190,102	368,216	381,955
Total costs and expenses	6,578,772	6,436,209	13,496,755	13,349,078
Operating Income	1,197,341	1,492,634	1,962,475	2,548,645
Other Income (Expense):
Gains (losses) on marketable securities	72,019	(379,332)	(168,439)	(410,733)
Other income	338	12,927	8,680	16,997
Interest expense	(441,917)	(551,126)	(904,626)	(1,046,088)
Total other (expense) income	(369,560)	(917,531)	(1,064,385)	(1,439,824)
Income before income tax expense	827,781	575,103	898,090	1,108,821
Income tax expense	(273,195)	(219,318)	(296,396)	(470,181)
Net income	$ 554,586	$ 355,785	$ 601,694	$ 638,640
Net income per common share - basic	$ 0.07	$ 0.04	$ 0.07	$ 0.08
Weighted average common shares outstanding - basic	8,055,476	8,080,161	8,055,315	8,081,149
Net income per common share - diluted	$ 0.07	$ 0.04	$ 0.07	$ 0.08
Weighted average common shares outstanding - diluted	8,055,476	8,125,720	8,055,332	8,158,744
Processing and Storage Fees [Member]
Revenue	$ 7,715,446	$ 7,871,719	$ 15,358,559	$ 15,737,607
Public Banking Revenue [Member]
Revenue	46,485	42,688	47,895	124,767
Product Revenue [Member]
Revenue	$ 14,182	$ 14,436	$ 52,776	$ 35,349

Consolidated Statements of Cash Flows - USD ($)	6 Months Ended
Consolidated Statements of Cash Flows - USD ($)	May 31, 2026	May 31, 2025
Cash flows from operating activities:
Net income	$ 601,694	$ 638,640
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization expense	487,845	498,141
Loss on sale of property and equipment	0	47,671
Losses on marketable securities	168,439	410,733
Compensatory element of stock options	223,453	337,418
Provision for doubtful accounts	534,124	366,586
Amortization of debt issuance costs	10,245	10,465
Amortization of operating lease right-of-use asset	197,683	186,114
Changes in assets and liabilities:
Accounts receivable	(598,023)	11,034
Prepaid expenses	65,471	15,710
Inventory	114,624	58,219
Other current assets	219,594	62,265
Deposits and other assets, net	(33,545)	(61,694)
Accounts payable	(23,667)	370,932
Accrued expenses	(1,310,813)	(3,136,174)
Operating lease liability	(222,297)	(203,016)
Deferred revenue	2,062,911	2,048,033
Net cash from operating activities	2,497,738	1,661,077
Cash flows from investing activities:
Purchases of property and equipment	(99,766)	(124,461)
Sale of property and equipment	0	115,000
Purchases of marketable securities	(656,703)	(2,574,249)
Sale of marketable securities	810,612	793,426
Net cash from (used) in investing activities	54,143	(1,790,284)
Cash flows used in financing activities:
Treasury stock purchases	0	(88,619)
Repayments of note payable	(86,860)	(74,416)
Repayment of line of credit	(3,500,000)	(3,700,000)
Proceeds from the exercise of stock options	23,250	0
Proceeds from line of credit	1,200,000	6,800,000
Dividends paid	0	(3,231,227)
Net cash used in financing activities	(2,363,610)	(294,262)
Increase (Decrease) in cash and cash equivalents	188,271	(423,469)
Cash and cash equivalents - beginning of period	319,031	560,960
Cash and cash equivalents - end of period	507,302	137,491
Supplemental cash flow information:
Interest	899,859	977,952
Income taxes	$ 77,084	$ 2,198,330

Consolidated Balance Sheets - USD ($)	May 31, 2026	Nov. 30, 2025
Current Assets
Cash and cash equivalents	$ 507,302	$ 319,031
Marketable securities	2,654,665	2,977,013
Accounts receivable (net of allowance for doubtful accounts of $4,368,665 and $4,306,410, respectively)	6,910,079	6,846,180
Prepaid expenses	507,747	573,218
Inventory, current portion	310,170	408,794
Other current assets	414,391	633,985
Total current assets	11,304,354	11,758,221
Property and Equipment-net	20,668,602	21,034,372
Other Assets
Intangible assets, net	840,765	863,074
Inventory, net of current portion	760,000	776,000
Goodwill	1,941,411	1,941,411
Deferred tax assets	23,620,711	23,620,711
Operating lease right-of-use asset	621,943	819,626
Deposits and other assets, net	948,644	915,099
Total other assets	28,733,474	28,935,921
Total assets	60,706,430	61,728,514
Current Liabilities
Accounts payable	2,847,104	2,870,771
Accrued expenses	2,967,214	4,278,027
Note payable	195,135	183,650
Line of credit	0	2,300,000
Current portion of operating lease liability	421,888	430,221
Deferred revenue	9,498,548	9,730,318
Total current liabilities	15,929,889	19,792,987
Other Liabilities
Deferred revenue, net of current portion	53,269,359	50,974,678
Note payable, net of current portion and debt issuance costs	8,082,030	8,170,130
Operating lease long-term liability	260,664	474,628
Long-term liability - revenue sharing agreements	875,000	875,000
Other liabilities	47,020	47,020
Total other liabilities	62,534,073	60,541,456
Total liabilities	78,463,962	80,334,443
Commitments and contingencies (Note 9)	0	0
Stockholders' Deficit
Preferred stock	0	0
Common stock ($.01 par value, 20,000,000 authorized; 14,884,619 issued and 8,062,650 outstanding as of May 31, 2026 and 14,877,119 issued and 8,055,150 outstanding as of November 30, 2025)	148,846	148,771
Additional paid-in capital	44,955,224	44,708,596
Treasury stock, at cost	(25,025,058)	(25,025,058)
Accumulated deficit	(37,836,544)	(38,438,238)
Total stockholders' deficit	(17,757,532)	(18,605,929)
Total liabilities and stockholders' deficit	60,706,430	61,728,514
Series A Junior Participating Preferred Stock [Member]
Stockholders' Deficit
Preferred stock	$ 0	$ 0